Existing drugs could fight Alzheimer's
The Washington Times explores the ongoing research that is taking a second look at some existing therapies as potential treatments for Alzheimer's. Neil Buckholtz, chief of the Dementias of Aging Branch of the National Institute on Aging, is hopeful that statins and Avandia could prove beneficial. Much of the research is focused on inhibiting enzymes that promote amyloid, the plaque that is linked to damage of brain tissue.
- here's the report on Alzheimer's from The Washington Times
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
